An interview with Sheila Collins, Ph.D. Interview by Vicki Glaser.
Publication
, Journal Article
Collins, S
Published in: Assay Drug Dev Technol
June 2005
Duke Scholars
Published In
Assay Drug Dev Technol
DOI
ISSN
1540-658X
Publication Date
June 2005
Volume
3
Issue
3
Start / End Page
253 / 260
Location
United States
Related Subject Headings
- Signal Transduction
- Receptors, Adrenergic, beta
- Obesity
- Medicinal & Biomolecular Chemistry
- Lipid Metabolism
- Humans
- Animals
- 3404 Medicinal and biomolecular chemistry
- 3214 Pharmacology and pharmaceutical sciences
- 1115 Pharmacology and Pharmaceutical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Collins, S. (2005). An interview with Sheila Collins, Ph.D. Interview by Vicki Glaser. Assay Drug Dev Technol, 3(3), 253–260. https://doi.org/10.1089/adt.2005.3.253
Collins, Sheila. “An interview with Sheila Collins, Ph.D. Interview by Vicki Glaser.” Assay Drug Dev Technol 3, no. 3 (June 2005): 253–60. https://doi.org/10.1089/adt.2005.3.253.
Collins S. An interview with Sheila Collins, Ph.D. Interview by Vicki Glaser. Assay Drug Dev Technol. 2005 Jun;3(3):253–60.
Collins, Sheila. “An interview with Sheila Collins, Ph.D. Interview by Vicki Glaser.” Assay Drug Dev Technol, vol. 3, no. 3, June 2005, pp. 253–60. Pubmed, doi:10.1089/adt.2005.3.253.
Collins S. An interview with Sheila Collins, Ph.D. Interview by Vicki Glaser. Assay Drug Dev Technol. 2005 Jun;3(3):253–260.
Published In
Assay Drug Dev Technol
DOI
ISSN
1540-658X
Publication Date
June 2005
Volume
3
Issue
3
Start / End Page
253 / 260
Location
United States
Related Subject Headings
- Signal Transduction
- Receptors, Adrenergic, beta
- Obesity
- Medicinal & Biomolecular Chemistry
- Lipid Metabolism
- Humans
- Animals
- 3404 Medicinal and biomolecular chemistry
- 3214 Pharmacology and pharmaceutical sciences
- 1115 Pharmacology and Pharmaceutical Sciences